Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Mercurna Logo
Mercurna Growth Score
67
CB Rank
191162
Heat Score
69
Mercurna is a biotechnology start-up that develops messenger RNA-based medicines.
Founded
obfuscation
PrivateGrant Oss, Noord-Brabant, The Netherlands1-10 mercurna.com/
Biopharma
Biotechnology
Overview

Mercurna
Total Funding
obfuscation
Growth Score
67
Heat Score
69

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score67
-6 pts
in past quarter
Heat Score 69
-1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Mercurna

CB Rank
191162
Mercurna is a biotechnology start-up that develops messenger RNA-based medicines.
Founded
obfuscation
PrivateGrant Oss, Noord-Brabant, The Netherlands1-10 mercurna.com/
Biopharma
Biotechnology

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Jurgen Dieker, Roland Brock, Sander van Asbeck
About the Company

Mercurna is a developer of life-changing mRNA medicines. They also develop modular nanomedicines that can be adapted to a multitude of diseases with ease. They built a sustainable business that keeps on providing society with truly valuable medicines. They also provide mRNA medicines particularly suited to the treatment of chronic inflammatory

diseases.

Contact Email info@mercurna.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

mCura1
An mRNA-based therapeutic formulation designed to treat inflammation in the kidney by delivering therapeutic proteins directly to the glomerulus to restore homeostasis.
Modular Nanomedicine Platform Technology
A platform combining cell-targeting ligands with lipid-based delivery vehicles to deliver engineered mRNA specifically to diseased tissues for various inflammatory conditions.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Mercurna Logo
Grant - Mercurna
1
obfuscation
— Grant
obfuscation
Grant - Mercurna Logo
Grant - Mercurna
1
obfuscation
— Grant
obfuscation
Grant - Mercurna Logo
Grant - Mercurna
1
obfuscation
— Grant
obfuscation
Grant - Mercurna Logo
Grant - Mercurna
1
obfuscation
— Grant
obfuscation
Grant - Mercurna Logo
Grant - Mercurna
1
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Mercurna Logo
Grant - Mercurna
1
obfuscation
— Grant
obfuscation
Grant - Mercurna Logo
Grant - Mercurna
1
obfuscation
— Grant
obfuscation
Grant - Mercurna Logo
Grant - Mercurna
1
obfuscation
— Grant
obfuscation
Grant - Mercurna Logo
Grant - Mercurna
1
obfuscation
— Grant
obfuscation
Grant - Mercurna Logo
Grant - Mercurna
1
obfuscation
— Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
EISMEA Logo
EISMEA
—
Grant - Mercurna Logo
Grant - Mercurna
—
EISMEA Logo
EISMEA
—
Grant - Mercurna Logo
Grant - Mercurna
—
EISMEA Logo
EISMEA
—
Grant - Mercurna Logo
Grant - Mercurna
—
EISMEA Logo
EISMEA
—
Grant - Mercurna Logo
Grant - Mercurna
—
EISMEA Logo
EISMEA
—
Grant - Mercurna Logo
Grant - Mercurna
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

170
286.36%
 in past month

IT Spend

$54.2KThis year, Mercurna is projected to spend $54.2K on IT, according to Aberdeen.

Active Website Tech Count

3Mercurna is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, Viewport Meta, and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Mercurna's headquarters? Mercurna is located in Oss, Noord-Brabant, The Netherlands.Who invested in Mercurna? Mercurna is funded by EISMEA.When was the last funding round for Mercurna? Mercurna closed its last funding round on
obfuscation
from a Grant round.Who are Mercurna's competitors? Alternatives and possible competitors to Mercurna may include Moderna, ReCode Therapeutics, and  Capstan Therapeutics.How much funding has Mercurna raised to date? Mercurna has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|